JENNIFER COOK: Open Payments
NPI 1073858049 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 27 payments from 9 companies in 2025. Trend: 2023 $1,088 · 2024 $1,000 · 2025 $898
Food & beverage: $815Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $370 |
| Arcutis Biotherapeutics, Inc. | 2 | $154 |
| Galderma Laboratories, L.P. | 2 | $95 |
| Janssen Biotech, Inc. | 1 | $83 |
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| Incyte Corporation | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Organon LLC | 2 | $29 |
| UCB, Inc. | 1 | $16 |
Products named: RINVOQ, SKYRIZI, TREMFYA, NEMLUVIO, OPZELURA, BOTOX, COSENTYX, DUPIXENT.
Industry payments across ID — which companies pay providers there.
